Elaine A. Forster

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

Elaine A. Forster, Ian A. Cliffe, David J. Bill et al. · European Journal of Pharmacology · 1995 · 609 citations

Molecular Pharmacology, Biochemistry, Functional Selectivity +8

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

Allan Fletcher, Elaine A. Forster, David J. Bill et al. · Behavioural Brain Research · 1995 · 521 citations

Neurophysiology, Behavioral Neuroscience, Medicine +14

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

Allan Fletcher, David J. Bill, Sarah J. Bill et al. · European Journal of Pharmacology · 1993 · 220 citations

Functional Selectivity, Medicine, Synaptic Transmission +8

Direct evidence for an important species difference in the mechanism of 8‐OH‐DPAT‐induced hypothermia

David J. Bill, Martha Knight, Elaine A. Forster et al. · British Journal of Pharmacology · 1991 · 174 citations · Full text

(S)-N-tert-Butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

Ian A. Cliffe, Christopher I. Brightwell, Allan Fletcher et al. · Journal of Medicinal Chemistry · 1993 · 81 citations · Full text

Altmetric Attention Score, Molecular Biology, Peptide Science +19